Literature DB >> 19708041

Regional Fos expression induced by morphine withdrawal in the 7-day-old rat.

Anika A McPhie1, Gordon A Barr.   

Abstract

Human infants are often exposed to opiates chronically but the mechanisms by which opiates induce dependence in the infant are not well studied. In the adult the brain regions involved in the physical signs of opiate withdrawal include the periaqueductal gray area, the locus coeruleus, amygdala, ventral tegmental area, nucleus accumbens, hypothalamus, and spinal cord. Microinjection studies show that many of these brain regions are involved in opiate withdrawal in the infant rat. Our goal here was to determine if these regions become metabolically active during physical withdrawal from morphine in the infant rat as they do in the adult. Following chronic morphine or saline treatment, withdrawal was precipitated in 7-day-old pups with the opiate antagonist naltrexone. Cells positive for Fos-like immunoreactivity were quantified within select brain regions. Increased Fos-like labeled cells were found in the periaqueductal gray, nucleus accumbens, locus coeruleus, and spinal cord. These are consistent with other studies showing that the neural circuits underlying the physical signs of opiate withdrawal are similar in the infant and adult.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19708041      PMCID: PMC6040917          DOI: 10.1002/dev.20392

Source DB:  PubMed          Journal:  Dev Psychobiol        ISSN: 0012-1630            Impact factor:   3.038


  70 in total

1.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

2.  Increased fos-like immunoreactivity in the periaqueductal gray of anaesthetised rats during opiate withdrawal.

Authors:  B Chieng; K A Keay; M J Christie
Journal:  Neurosci Lett       Date:  1995-01-02       Impact factor: 3.046

3.  Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal.

Authors:  G F Koob; T L Wall; F E Bloom
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  A specific limbic circuit underlies opiate withdrawal memories.

Authors:  François Frenois; Luis Stinus; Francesco Di Blasi; Martine Cador; Catherine Le Moine
Journal:  J Neurosci       Date:  2005-02-09       Impact factor: 6.167

Review 5.  Opioid tolerance and dependence in infants and children.

Authors:  K J Anand; J H Arnold
Journal:  Crit Care Med       Date:  1994-02       Impact factor: 7.598

6.  Naloxone-precipitated morphine withdrawal elicits increases in c-fos mRNA expression in restricted regions of the infant rat brain.

Authors:  Takehiko Maeda; Shiroh Kishioka; Norihiro Inoue; Norifumi Shimizu; Yohji Fukazawa; Masanobu Ozaki; Hiroyuki Yamamoto
Journal:  Jpn J Pharmacol       Date:  2002-11

7.  Time action profiles of regional cerebral glucose utilization during naloxone-precipitated morphine withdrawal.

Authors:  W A Geary; G F Wooten
Journal:  Brain Res       Date:  1986-12-03       Impact factor: 3.252

8.  Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation.

Authors:  L S Franck; J Vilardi; D Durand; R Powers
Journal:  Am J Crit Care       Date:  1998-09       Impact factor: 2.228

9.  Ontogeny of NMDA receptor-mediated morphine tolerance in the postnatal rat.

Authors:  Hongbo Zhu; Gordon A Barr
Journal:  Pain       Date:  2003-08       Impact factor: 6.961

10.  Spinal cord mechanisms of opioid tolerance and dependence: Fos-like immunoreactivity increases in subpopulations of spinal cord neurons during withdrawal [corrected].

Authors:  D S Rohde; D J Detweiler; A I Basbaum
Journal:  Neuroscience       Date:  1996-05       Impact factor: 3.590

View more
  7 in total

1.  The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats.

Authors:  Shuanglin Hao; Shue Liu; Xuexing Zheng; Wenwen Zheng; Handong Ouyang; Marina Mata; David J Fink
Journal:  Neuropsychopharmacology       Date:  2010-11-10       Impact factor: 7.853

Review 2.  Changing mechanisms of opiate tolerance and withdrawal during early development: animal models of the human experience.

Authors:  Gordon A Barr; Anika McPhie-Lalmansingh; Jessica Perez; Michelle Riley
Journal:  ILAR J       Date:  2011

3.  A Conantokin Peptide Con-T[M8Q] Inhibits Morphine Dependence with High Potency and Low Side Effects.

Authors:  Zhuguo Liu; Zheng Yu; Shuo Yu; Cui Zhu; Mingxin Dong; Wenxiang Mao; Jie Hu; Mary Prorok; Ruibin Su; Qiuyun Dai
Journal:  Mar Drugs       Date:  2021-01-19       Impact factor: 5.118

Review 4.  Prenatal Opioid Exposure Enhances Responsiveness to Future Drug Reward and Alters Sensitivity to Pain: A Review of Preclinical Models and Contributing Mechanisms.

Authors:  Gregory G Grecco; Brady K Atwood
Journal:  eNeuro       Date:  2020-10-15

5.  GPR171 activation regulates morphine tolerance but not withdrawal in a test-dependent manner in mice.

Authors:  Leela Afrose; Max V McDermott; Ashif I Bhuiyan; Sanjai K Pathak; Erin N Bobeck
Journal:  Behav Pharmacol       Date:  2022-08-05       Impact factor: 2.277

6.  Opioid analgesia in mechanically ventilated children: results from the multicenter Measuring Opioid Tolerance Induced by Fentanyl study.

Authors:  Kanwaljeet J S Anand; Amy E Clark; Douglas F Willson; John Berger; Kathleen L Meert; Jerry J Zimmerman; Rick Harrison; Joseph A Carcillo; Christopher J L Newth; Stephanie Bisping; Richard Holubkov; J Michael Dean; Carol E Nicholson
Journal:  Pediatr Crit Care Med       Date:  2013-01       Impact factor: 3.624

Review 7.  An emerging new paradigm in opioid withdrawal: a critical role for glia-neuron signaling in the periaqueductal gray.

Authors:  Handong Ouyang; Shue Liu; Weian Zeng; Roy C Levitt; Keith A Candiotti; Shuanglin Hao
Journal:  ScientificWorldJournal       Date:  2012-08-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.